Silphium Asset Management LTD Seagen Inc. Transaction History

Silphium Asset Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2025	SELL	$0.0 - $228.9 $0 - $28.6 Million	-125,000 Closed	0 $0
Q3 2023 Jan 30, 2025	BUY	$191.51 - $216.16 $12.4 Million - $14.1 Million	65,000 Added 108.33%	125,000 $26.5 Billion
Q2 2023 Jan 30, 2025	BUY	$187.64 - $206.25 $11.3 Million - $12.4 Million	60,000 New	60,000 $11.5 Billion

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Silphium Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Silphium Asset Management LTD with notifications on news.